iglucose, Wireless Diabetes Management, Receives FDA Approval

Reading time: 1 – 2 minutes

iglucose is a mobile health device and wireless communication system for diabetes management. Recently cleared by the FDA, iglucose simplifies disease management by automatically collecting, storing and transmiting blood glucose readings to create logbooks and trend reports.

iglucose

From the iglucose website:

iglucose is a diabetes management solution that provides a convenient way to collect, store and automatically transmit blood glucose readings from compatible glucometers in real time. iglucose easily connects to industry leading, data-capable glucometers. Once glucometer data is transmitted to a secure central database, logbooks and trend reports are automatically created and can be communicated to individuals, family members, caregivers and health care professionals in order to collaborate for better outcomes. iglucose is mobile: it can be used anytime, anywhere.

The iglucose is the first core product in a suite of diabetes management technologies from PositiveID Corporation.

Source: PRWeb

About the Author

Walter Jessen, Ph.D. is a Data Scientist, Digital Biologist, and Knowledge Engineer. His primary focus is to build and support expert systems, including AI (artificial intelligence) and user-generated platforms, and to identify and develop methods to capture, organize, integrate, and make accessible company knowledge. His research interests include disease biology modeling and biomarker identification. He is also a Principal at Highlight Health Media, which publishes Highlight HEALTH, and lead writer at Highlight HEALTH.